[The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic].

Autor: Avdeev SN; Sechenov First Moscow State Medical University (Sechenov University)., Chulanov VP; Sechenov First Moscow State Medical University (Sechenov University).; National Medical Research Center for Phthisiopulmonology and Infectious Diseases., Alexeeva EI; Sechenov First Moscow State Medical University (Sechenov University).; National Medical Research Center for Children's Health., Aleshina OA; National Medical Research Center for Hematology., Bereznikov AV; AlfaStrakhovanie-OMS LLC.; ROSBIOTECH University., Kotenko ON; City Clinical Hospital №52.; Pirogov Russian National Research Medical University., Lila AM; Nasonova Research Institute of Rheumatology.; Russian Medical Academy of Continuous Professional Education., Mutovina ZY; City Clinical Hospital №52.; Central State Medical Academy of the Administrative Department of the President of the Russian Federation., Parovichnikova EN; National Medical Research Center for Hematology., Fomina DS; Sechenov First Moscow State Medical University (Sechenov University).; City Clinical Hospital №52., Frolova NF; City Clinical Hospital №52.; Yevdokimov Moscow State University of Medicine and Dentistry., Shevchenko AO; Sechenov First Moscow State Medical University (Sechenov University).; Pirogov Russian National Research Medical University.; Shumakov National Medical Research Center for Transplantology and Artificial Organs.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2023 Oct 11; Vol. 95 (8), pp. 722-729. Date of Electronic Publication: 2023 Oct 11.

Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study.

Autor: Bryushkova EA; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia., Skatova VD; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Mutovina ZY; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia., Zagrebneva AI; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia., Fomina DS; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Kruglova TS; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia., Akopyan AA; Pirogov Russian National Research Medical University, Moscow, Russia., Strazhesko ID; Pirogov Russian National Research Medical University, Moscow, Russia., Lukyanov SA; Pirogov Russian National Research Medical University, Moscow, Russia., Tkacheva ON; Pirogov Russian National Research Medical University, Moscow, Russia., Lysenko MA; Pirogov Russian National Research Medical University, Moscow, Russia.; City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia., Chudakov DM; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.

Publikováno v: PloS one [PLoS One] 2022 Aug 24; Vol. 17 (8), pp. e0273340. Date of Electronic Publication: 2022 Aug 24 (Print Publication: 2022).

Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.

Autor: Putilina MV; Pirogov Russian National Research Medical University, Russian Ministry of Health, Moscow, Russia., Mutovina ZY; City Clinical Hospital No. 52, Moscow Health Department, Moscow, Russia., Kurushina OV; Volgograd State Medical University, Russian Ministry of Health, Volgograd, Russia., Khalilova DM; Azerbaijan State Medical University, Baku, Azerbaijan., Saverskaya EN; Moscow State University of Food Production, Moscow, Russia., Stepanova SB; South Ural State Medical University, Russian Ministry of Health, Chelyabinsk, Russia., Khoreva MA; Altai State Medical University, Russian Ministry of Health, Barnaul, Russia., Starikov AS; Pitirim Sorokin Syktyvkar State University, Syktyvkar, Russia.

Publikováno v: Neuroscience and behavioral physiology [Neurosci Behav Physiol] 2022; Vol. 52 (6), pp. 836-841. Date of Electronic Publication: 2022 Oct 26.

[Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19].

Autor: Kruglova TS; City Clinical Hospital №52., Fomina DS; City Clinical Hospital №52.; Sechenov First Moscow State Medical University (Sechenov University)., Poteshkina NG; City Clinical Hospital №52.; Pirogov Russian National Research Medical University., Frolova NF; City Clinical Hospital №52., Beloglazova IP; City Clinical Hospital №52.; Pirogov Russian National Research Medical University., Mutovina ZY; City Clinical Hospital №52.; Central State Medical Academy of the President of the Russian Federation., Samsonova IV; City Clinical Hospital №52., Kovalevskaja EA; City Clinical Hospital №52., Zagrebneva AI; City Clinical Hospital №52.; Pirogov Russian National Research Medical University., Serdotetckova SA; City Clinical Hospital №52., Chernov AA; City Clinical Hospital №52.; Russian Medical Academy of Continuous Professional Education., Lysenko MA; City Clinical Hospital №52.; Pirogov Russian National Research Medical University.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2021 Nov 15; Vol. 93 (11), pp. 1316-1324. Date of Electronic Publication: 2021 Nov 15.

[Hemophagocytic syndrome in a patient with adult-onset Still's disease: diagnostic problems].

Autor: Zakharova AY; Education and Research Medical Centre, Department for Presidential Affairs of the Russian Federation, Moscow, Russia; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Mutovina ZY; Education and Research Medical Centre, Department for Presidential Affairs of the Russian Federation, Moscow, Russia., Gordeev AV; Education and Research Medical Centre, Department for Presidential Affairs of the Russian Federation, Moscow, Russia; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Shestakova IN; Central Clinical Hospital with Polyclinic, Department for Presidential Affairs of the Russian Federation, Moscow, Russia; Peoples' Friendship University of Russia, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2015; Vol. 87 (5), pp. 84-89.